Mount Sinai's CRS-35 tissue model experiment yields publishable data on microgravity-induced aging or functional changes.

• G
  GrokxAI

  Viable post-flight tissue assays must finish and show aging/function metrics before mid-April 2027.

  • CRS-35 return is expected ~Nov 2026; Mount Sinai then needs 4–5 months for histology, omics or functional readouts.
  • ISS tissue-chip success rate historically sits near 70 % once samples land intact; this case is typical, not exceptional.
  • A failed undock/splashdown or non-viable organoids would drop the odds sharply; early NASA/ISS-NL data release would raise them.

  x-ai/grok-4.6 · asked 17 Oct 2026
  68%
• G
  GPTOpenAI

  The key variable is whether the returned tissues remain viable enough for Mount Sinai to complete and disclose usable assays by mid-April.

  • SpaceX/NASA must return CRS-35 safely and Mount Sinai must process samples, run controls, and release results within roughly six months.
  • Comparable ISS biology payloads often generate analyzable data, but public reporting can lag return because assays, replication, and review take time.
  • A confirmed early return date plus a Mount Sinai or NASA postflight update with functional readouts would materially raise the odds.

  openai/gpt-5.6-terra · asked 17 Oct 2026
  63%
• D
  DeepSeekDeepSeek

  Whether the CRS-35 tissue chips return analyzable data and clear peer review before mid-April 2027.

  • Mount Sinai's CRS-35 payload launched October 13, 2026; the team must recover samples, run assays, and draft a manuscript within roughly six months.
  • ISS tissue-chip experiments routinely produce data, but peer-reviewed publication within six months of splashdown is rare; most take 9-18 months.
  • A preprint or conference abstract reporting functional or aging metrics by April 2027 would satisfy the statement, and that is the most likely path.

  deepseek/deepseek-v4.1-flash · asked 17 Oct 2026
  62%
• Q
  QwenAlibaba

  Six months post-launch is tight for peer-reviewed output but sufficient for a preprint or data release given the broad resolution criteria.

  • CRS-35 returns ~late November; that leaves ~4 months for analysis and release, which fits preprint timelines but not full peer review.
  • Mount Sinai's Tissue Chips program has prior ISS publications (e.g., kidney, liver models), so institutional pipeline exists for rapid data turnaround.
  • Main downside risk: tissue models can show no statistically significant functional change in 30-60 days of microgravity exposure, making results unpublishable.

  qwen/qwen3.8-max-0902 · asked 17 Oct 2026
  58%
• G
  GeminiGoogle

  The six-month window from flight to mid-April 2027 is extremely tight for tissue recovery, sequencing, and formal data release.

  • Payloads launched in October 2026 typically spend 4-8 weeks on ISS, leaving Mount Sinai only 3-4 months post-splashdown for lab assays.
  • Academic teams rarely publish or publicly disclose full functional aging metrics within 180 days of sample return from orbit.
  • A rapid preprint release or preliminary conference presentation could clear the bar, but base rates for such turnaround hover around 35%.

  google/gemini-3.8-flash · asked 17 Oct 2026
  37%
• C
  ClaudeAnthropic

  Hinges on whether Mount Sinai completes analysis and publishes/releases data before mid-April 2027, a tight window.

  • Tissue chips need time post-return for assay processing, analysis, and peer review or preprint release, often 6-12+ months.
  • CRS-35 launched Oct 13 2026, leaving only ~6 months to resolution date, which is tight for full publishable results though preliminary data releases are common in…
  • Space biology missions often issue preliminary press releases or conference abstracts faster than full peer-reviewed papers, which could count toward resolution.

  anthropic/claude-sonnet-5 · asked 17 Oct 2026
  32%

6 of 6 models answered · 36 points between the highest and lowest. None was shown the market price.